• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的原发性HIV-1感染中中枢神经系统免疫激活的渐进性增加。

Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.

作者信息

Suh Joome, Sinclair Elizabeth, Peterson Julia, Lee Evelyn, Kyriakides Tassos C, Li Fang-Yong, Hagberg Lars, Fuchs Dietmar, Price Richard W, Gisslen Magnus, Spudich Serena

机构信息

Yale School of Medicine, 367 Cedar Street, New Haven, CT 06510, USA.

Department of Medicine, UCSF School of Medicine, 1001 Potrero Avenue, SFGH 100, San Francisco, CA, 94143, USA.

出版信息

J Neuroinflammation. 2014 Dec 3;11:199. doi: 10.1186/s12974-014-0199-y.

DOI:10.1186/s12974-014-0199-y
PMID:25465205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4263211/
Abstract

BACKGROUND

Central nervous system (CNS) inflammation is a mediator of brain injury in HIV infection. To study the natural course of CNS inflammation in the early phase of infection, we analyzed longitudinal levels of soluble and cellular markers of inflammation in cerebrospinal fluid (CSF) and blood, beginning with primary HIV-1 infection (PHI).

METHODS

Antiretroviral-naïve subjects identified as having PHI (less than one year since HIV transmission) participated in phlebotomy and lumbar puncture at baseline and at variable intervals thereafter. Mixed-effects models were used to analyze longitudinal levels of CSF neopterin and percentages of activated cluster of differentiation (CD)4+ and CD8+ T-cells (co-expressing CD38 and human leukocyte antigen-D-related (HLA-DR)) in blood and CSF.

RESULTS

A total of 81 subjects were enrolled at an average of 100 days after HIV transmission and had an average follow-up period of 321 days, with the number of visits ranging from one to 13. At baseline, the majority of subjects had CSF neopterin concentrations above the upper limit of normal. The baseline concentration was associated with the longitudinal trajectory of CSF neopterin. In subjects with baseline levels of less than 21 nmol/L, a cutoff value obtained from a mixed-effects model, CSF neopterin increased by 2.9% per 10 weeks (n = 33; P <0.001), whereas it decreased by 6.7% in subjects with baseline levels of more than 21 nmol/L (n = 11; P = 0.001). In a subset with available flow cytometry data (n = 42), the percentages of activated CD4+ and CD8+ T-cells in CSF increased by 0.8 (P <0.001) and 0.73 (P = 0.02) per 10 weeks, respectively.

CONCLUSIONS

Neopterin levels and the percentages of activated CD4+ and CD8+ T-cells in CSF progressively increase in most subjects without treatment during early HIV-1 infection, suggesting an accrual of intrathecal inflammation, a major contributor to neuropathology in HIV infection.

摘要

背景

中枢神经系统(CNS)炎症是HIV感染中脑损伤的介质。为了研究感染早期CNS炎症的自然病程,我们分析了从原发性HIV-1感染(PHI)开始的脑脊液(CSF)和血液中炎症的可溶性和细胞标志物的纵向水平。

方法

被确定为患有PHI(自HIV传播以来不到一年)且未接受过抗逆转录病毒治疗的受试者在基线时以及此后的不同时间间隔接受静脉穿刺和腰椎穿刺。混合效应模型用于分析CSF新蝶呤的纵向水平以及血液和CSF中活化的分化簇(CD)4+和CD8+ T细胞(共表达CD38和人类白细胞抗原-D相关分子(HLA-DR))的百分比。

结果

共有81名受试者在HIV传播后平均100天入组,平均随访期为3​​21天,就诊次数从1次到13次不等。在基线时,大多数受试者的CSF新蝶呤浓度高于正常上限。基线浓度与CSF新蝶呤的纵向轨迹相关。在基线水平低于21 nmol/L(从混合效应模型获得的临界值)的受试者中,CSF新蝶呤每10周增加2.9%(n = 33;P <0.001),而在基线水平高于21 nmol/L的受试者中则下降6.7%(n = 11;P = 0.001)。在有可用流式细胞术数据的亚组(n = 42)中,CSF中活化的CD4+和CD8+ T细胞百分比每10周分别增加0.8(P <0.001)和0.73(P = 0.02)。

结论

在早期HIV-1感染期间,大多数未经治疗的受试者CSF中的新蝶呤水平以及活化的CD4+和CD8+ T细胞百分比逐渐增加,提示鞘内炎症的累积,这是HIV感染神经病理学的主要促成因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d66/4263211/e598a66a23d4/12974_2014_199_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d66/4263211/30dfd6efdc8c/12974_2014_199_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d66/4263211/e598a66a23d4/12974_2014_199_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d66/4263211/30dfd6efdc8c/12974_2014_199_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d66/4263211/e598a66a23d4/12974_2014_199_Fig2_HTML.jpg

相似文献

1
Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.未经治疗的原发性HIV-1感染中中枢神经系统免疫激活的渐进性增加。
J Neuroinflammation. 2014 Dec 3;11:199. doi: 10.1186/s12974-014-0199-y.
2
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.中枢神经系统免疫激活是原发性人类免疫缺陷病毒 1 感染的特征,即使在脑脊液病毒载量最小的参与者中也是如此。
J Infect Dis. 2011 Sep 1;204(5):753-60. doi: 10.1093/infdis/jir387.
3
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.未治疗的 HIV-1 感染、中枢神经系统损伤和病毒抑制过程中脑脊液炎症的分隔。
PLoS One. 2021 May 13;16(5):e0250987. doi: 10.1371/journal.pone.0250987. eCollection 2021.
4
Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study.未接受抗逆转录病毒治疗的HIV-1感染患者的脑脊液病毒载量:一项纵向研究。
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):291-5. doi: 10.1097/00042560-199804010-00001.
5
Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.脑脊液中可溶性CD14与未经治疗的HIV感染患者的炎症和轴突损伤标志物相关:一项回顾性横断面研究。
BMC Infect Dis. 2016 Apr 21;16:176. doi: 10.1186/s12879-016-1510-6.
6
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.在接受高效抗逆转录病毒治疗4年以上后,中枢神经系统的免疫激活仍然存在。
J Infect Dis. 2007 Dec 15;196(12):1779-83. doi: 10.1086/523648.
7
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.HIV感染期间脑脊液中免疫刺激标志物的纵向研究
Scand J Infect Dis. 1994;26(5):523-33. doi: 10.3109/00365549409011810.
8
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.抗逆转录病毒治疗对免疫激活的作用可降低脑脊液中HIV-1感染。
J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):544-52. doi: 10.1097/QAI.0b013e318162754f.
9
Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation.原发性 HIV 感染中的周围神经病与全身和中枢神经系统免疫激活有关。
J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):303-10. doi: 10.1097/QAI.0000000000000167.
10
Cerebral white matter integrity during primary HIV infection.原发性HIV感染期间的脑白质完整性
AIDS. 2015 Feb 20;29(4):433-42. doi: 10.1097/QAD.0000000000000560.

引用本文的文献

1
Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infection.原发性HIV感染开始抗逆转录病毒治疗前后中枢神经系统以及全身T淋巴细胞和单核细胞的纵向激活情况。
Front Immunol. 2025 Feb 25;16:1531828. doi: 10.3389/fimmu.2025.1531828. eCollection 2025.
2
Central Nervous System Effects of Early HIV Infection and Consequences of Antiretroviral Therapy Initiation during Acute HIV.早期 HIV 感染对中枢神经系统的影响及急性 HIV 感染时开始抗逆转录病毒治疗的后果。
Viruses. 2024 Jul 5;16(7):1082. doi: 10.3390/v16071082.
3
A Canadian Survey of Research on HIV-1 Latency-Where Are We Now and Where Are We Heading?

本文引用的文献

1
Restrictions to HIV-1 replication in resting CD4+ T lymphocytes.静止 CD4+T 淋巴细胞中 HIV-1 复制的限制。
Cell Res. 2013 Jul;23(7):876-85. doi: 10.1038/cr.2013.74. Epub 2013 Jun 4.
2
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy.抗逆转录病毒治疗开始后脑脊液中新蝶呤的衰减特征。
J Neuroinflammation. 2013 May 10;10:62. doi: 10.1186/1742-2094-10-62.
3
Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.
一项加拿大的 HIV-1 潜伏研究调查——我们现在在哪里,我们将走向何方?
Viruses. 2024 Feb 1;16(2):229. doi: 10.3390/v16020229.
4
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management.HIV 相关认知障碍的发病机制和管理的新疗法。
Nat Rev Neurol. 2023 Nov;19(11):668-687. doi: 10.1038/s41582-023-00879-y. Epub 2023 Oct 10.
5
Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV.在 HIV 感染者中,神经炎症的增加与神经退行性变的增加有关。
Viruses. 2023 Aug 30;15(9):1835. doi: 10.3390/v15091835.
6
The potential role of HIV-1 latency in promoting neuroinflammation and HIV-1-associated neurocognitive disorder.HIV-1 潜伏期在促进神经炎症和 HIV-1 相关神经认知障碍中的潜在作用。
Trends Immunol. 2022 Aug;43(8):630-639. doi: 10.1016/j.it.2022.06.003. Epub 2022 Jul 12.
7
HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance.在原发性 HIV 感染期间,HIV 疾病动力学与炎症和中枢神经系统损伤标志物及其与认知表现的关系。
J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):183-190. doi: 10.1097/QAI.0000000000002832.
8
Permeation Challenges of Drugs for Treatment of Neurological Tuberculosis and HIV and the Application of Magneto-Electric Nanoparticle Drug Delivery Systems.治疗神经型结核病和艾滋病药物的渗透挑战及磁电纳米颗粒药物递送系统的应用
Pharmaceutics. 2021 Sep 15;13(9):1479. doi: 10.3390/pharmaceutics13091479.
9
HIV-Proteins-Associated CNS Neurotoxicity, Their Mediators, and Alternative Treatments.HIV 蛋白相关中枢神经系统神经毒性、其介质和替代治疗方法。
Cell Mol Neurobiol. 2022 Nov;42(8):2553-2569. doi: 10.1007/s10571-021-01151-x. Epub 2021 Sep 25.
10
Distinct cellular immune properties in cerebrospinal fluid are associated with cognition in HIV-infected individuals initiating antiretroviral therapy.在开始接受抗逆转录病毒治疗的 HIV 感染者中,脑脊液中独特的细胞免疫特性与认知功能相关。
J Neuroimmunol. 2020 Jul 15;344:577246. doi: 10.1016/j.jneuroim.2020.577246. Epub 2020 Apr 27.
脑脊液和神经影像学生物标志物异常提示在原发性 HIV 感染的部分个体中存在早期神经损伤。
J Infect Dis. 2013 Jun 1;207(11):1703-12. doi: 10.1093/infdis/jit088. Epub 2013 Mar 4.
4
HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.HIV-1 相关中枢神经系统疾病:发病机制、诊断和治疗的当前问题。
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007120. doi: 10.1101/cshperspect.a007120.
5
Central nervous system viral invasion and inflammation during acute HIV infection.急性 HIV 感染期间的中枢神经系统病毒侵袭和炎症。
J Infect Dis. 2012 Jul 15;206(2):275-82. doi: 10.1093/infdis/jis326. Epub 2012 May 2.
6
Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy.强化拉替拉韦治疗并未改变抑制性治疗患者的脑脊液 HIV-1 感染或免疫激活。
J Infect Dis. 2011 Dec 15;204(12):1936-45. doi: 10.1093/infdis/jir667. Epub 2011 Oct 21.
7
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.中枢神经系统免疫激活是原发性人类免疫缺陷病毒 1 感染的特征,即使在脑脊液病毒载量最小的参与者中也是如此。
J Infect Dis. 2011 Sep 1;204(5):753-60. doi: 10.1093/infdis/jir387.
8
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.在高效抗逆转录病毒治疗时代,HIV 相关神经认知障碍仍然存在:CHARTER 研究。
Neurology. 2010 Dec 7;75(23):2087-96. doi: 10.1212/WNL.0b013e318200d727.
9
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.脑脊液中新蝶呤:HIV-1 感染中中枢神经系统免疫激活的有价值的生物标志物。
AIDS Res Ther. 2010 Jun 3;7:15. doi: 10.1186/1742-6405-7-15.
10
Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.在早期HIV感染期间观察到的磁共振波谱神经元标志物和T细胞表型的变化。
Neurology. 2009 Apr 28;72(17):1465-72. doi: 10.1212/WNL.0b013e3181a2e90a.